###begin article-title 0
###xml 13 23 13 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">optineurin</italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Variation in optineurin (OPTN) allele frequencies between and within populations
###end article-title 0
###begin p 1
The first two authors contributed equally to this publication.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
###xml 49 59 49 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">optineurin</italic>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
To evaluate the extent to which mutations in the optineurin (OPTN) glaucoma gene play a role in glaucoma in different populations.
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Case-controlled study of OPTN sequence variants in individuals with or without glaucoma in populations of different ancestral origins and evaluate previous OPTN reports. We analyzed 314 subjects with African, Asian, Caucasian and Hispanic ancestries included 229 cases of primary open-angle glaucoma, 51 cases of juvenile-onset open-angle glaucoma, 33 cases of normal tension glaucoma, and 371 controls. Polymerase chain reaction-amplified OPTN coding exons were resequenced and case frequencies were compared to frequencies in controls matched for ancestry.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 353 357 353 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
The E50K sequence variant was identified in one individual from Chile with normal tension glaucoma, and the 691_692insAG variant was found in one Ashkenazi Jewish individual from Russia. The R545Q variant was found in two Asian individuals with primary open-angle glaucoma; one of Filipino ancestry and one of Korean ancestry. In addition to presenting OPTN allele frequencies for Caucasian and Asian populations that have been the subject of previous reports, we also present information for populations of Hispanic and black African ancestries.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Our study contributes additional evidence to support the previously reported association of the OPTN E50K mutation with glaucoma. After finding an additional 691_692insAG OPTN variant, we can still only conclude that this variant is rare. Combined analysis of our data with data from more than a dozen other studies indicates no association of R545Q with glaucoma in most populations. Those same studies disagree in their conclusions regarding the role of M98K in glaucoma. Our analysis of the combined data provides statistically significant evidence of association of M98K with normal tension glaucoma in Asian populations, but not in Caucasian populations; however, the validity of this conclusion is questionable because of large differences in allele frequencies between and within populations. It is currently not possible to tell how much of the underlying cause of the allele frequency difference is attributable to demographic, technical, or ascertainment differences among the studies.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
The optic neuropathy called glaucoma is the second most common cause of bilateral blindness in the world [1]. The most frequent form of glaucoma is open-angle glaucoma (OAG), which can occur as adult-onset primary open-angle glaucoma (POAG) or juvenile-onset primary open-angle glaucoma (JOAG). Prevalence of OAG has been measured at higher frequencies in individuals of African ancestry than in those of European or Asian ancestry [2]. Although the most common form of OAG in the US involves elevated intraocular pressure (IOP), OAG also develops in individuals whose IOP is never observed outside of the normal range (normal tension glaucoma, NTG). Associated risk factors for OAG include race (i.e., population genetic factors, particularly ethnic ancestry), a family history of glaucoma, increasing age, and an IOP elevated above the normal range.
###end p 12
###begin p 13
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 212 213 212 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 359 360 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
During the last decade, genetic mapping and cloning experiments have demonstrated that glaucoma has substantial genetic components [3]. Among the more than one dozen mapped glaucoma loci, 11 GLC1 loci cause OAG [3], two GLC3 loci cause congenital glaucoma [4,5], and the remaining known loci are responsible for secondary and developmental forms of glaucoma [3]. Additional genetic risk factors for differential severity of OAG have been reported [3].
###end p 13
###begin p 14
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
Mutations in the myocilin (MYOC) gene at the GLC1A locus are found in 2.6-4.3% of POAG cases [6] and up to one-third of the familial JOAG cases [7]. There has not yet been a follow-up on a recent report that mutations in WD repeat domain 36 (WDR36) that occur in cases of POAG that map to the GLC1G locus on chromosome 5 [8].
###end p 14
###begin p 15
###xml 15 16 15 16 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 45 55 45 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">optineurin</italic>
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 203 207 203 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 357 358 357 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
Rezaie et al. [9] described mutations in the optineurin (OPTN) gene, located within the GLC1E interval at 10p15-p14 [10], in 16.7% of families from a predominantly NTG population. The original report of OPTN involvement in glaucoma presented three likely disease-causing variants designated E50K, 691_692insAG, and R545Q, and one proposed risk factor M98K [9]. Further studies find association of some OPTN alleles with OAG, but others report no evidence of association of OAG with those same alleles [11-24].
###end p 15
###begin p 16
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 358 362 358 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
In this paper, we present new data on our OPTN mutation screening of 314 open-angle glaucoma patients who have either POAG, JOAG, or NTG, from populations of Caucasian, Asian, Hispanic, and African ancestry. We present case reports of individuals with E50K and 691_692insAG mutations and discuss findings from more than a dozen studies that have carried out OPTN mutation screening.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
Subjects
###end title 18
###begin p 19
###xml 40 51 <span type="species:ncbi:9606">participant</span>
###xml 178 183 <span type="species:ncbi:9606">human</span>
Informed consent was obtained from each participant according to a HIPAA-compliant study protocol approved by The University of Michigan Institutional Review Board for review of human subjects studies. Ophthalmologic examinations included slit-lamp biomicroscopy, optic disk examination, IOP by applanation, gonioscopy, and refraction. Individuals with known surgical or pharmacologic risk factors for glaucoma, such as steroid use, were excluded from this study.
###end p 19
###begin p 20
OAG was diagnosed based on the presence of open filtration angles, glaucomatous optic discs and glaucomatous visual field changes. Individuals with elevated IOP, greater than or equal to 22 mmHg, were considered to have POAG if they showed adult-onset at 35 years of age or older, and to have JOAG if they showed onset prior to 35 years of age. They were deemed to have NTG if their highest known IOP never exceeded 21 mmHg.
###end p 20
###begin p 21
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
Table 1 lists our study case and control subjects by their diagnosis and ancestry. Our 314 OAG subjects included 51 JOAG, 230 POAG, and 33 NTG cases. Our control samples came from 371 unrelated individuals. Normal control samples were matched for race to the cases, so that a sequence variant found in a particular case population had control screening carried out only in the control population of the same ancestry. In most cases, the sample screened was the proband of the family, but sometimes a different case from that family had to be used, such as when the proband was someone with an ambiguous diagnosis. For some families in which the proband had a sequence variant of interest, additional relatives were also screened. The group of normal control samples included samples from 48 individuals of African ancestry (Corielle Institute, Camden, NJ), 19 individuals of Hispanic ancestry, and 99 individuals of Asian ancestry (Corielle Institute) who had not been characterized for ophthalmologic phenotype. These uncharacterized population controls were used in a subset of experiments as detailed in Results.
###end p 21
###begin title 22
Ancestry and diagnosis of subjects.
###end title 22
###begin p 23
The frequency distribution of cases and controls according to open-angle glaucoma (OAG) condition and ancestry (national) in our analysis included 314 cases with juvenile onset OAG (JOAG), primary open-angle glaucoma (POAG), and normal tension glaucoma (NTG).
###end p 23
###begin title 24
Mutation Screening
###end title 24
###begin p 25
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 354 355 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 579 586 577 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 934 938 902 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 988 995 <span type="species:ncbi:9606">patient</span>
OPTN was screened via sequencing of polymerase chain reaction (PCR) amplified DNA. Genomic DNA was extracted from peripheral blood samples using Puregene DNA Isolation kits (Gentra Systems, Minneapolis, MN) following the manufacurer's protocol. OPTN coding exons were amplified by PCR in a 20 mul reaction containing 50 ng of genomic DNA, 1.5 mmol/l MgCl2, 0.5 mumol/l of each primer, 0.125 mmol/l of each dNTP, and 0.5 units of Amplitaq Gold (PE Applied Biosystems, Foster City, CA) in 1X final concentration of the PCR buffer. Primers used for exon amplification are listed in Table 2. PCR conditions were 10 min at 95 degreesC followed by 36 cycles of 1 min at 95 degreesC, 1 min at 55 degreesC, and 1 min at 72 degreesC with a final extension for 10 min at 72 degreesC. Sequencing of PCR-amplified DNA was used to screen all 314 OAG cases for mutations in the coding sequences (i.e., exons 4 through 16) and splice sites flanking OPTN exons. When a sequence variant was detected in a patient, we screened for that specific mutation in the control population samples of the same ancestry.
###end p 25
###begin title 26
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Primers used for sequencing the OPTN gene.
###end title 26
###begin p 27
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Primers used in amplification of OPTN exons were also used in sequencing reactions. Primers located in introns were placed far enough away from the exon boundaries to allow visualization of the sequence of the splice sites. Exons 4 through 16 are the exons that contain coding sequence.
###end p 27
###begin p 28
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 155 159 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 250 257 250 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
Individuals with E50K and 691_692insAG mutations who are presented in the case reports were screened for mutations in MYOC. PCR amplification of the three MYOC exons was conducted as described in reference [7] with some modified primers as listed in Table 3. PCR products were purified with a QIAquick PCR purification kit (Qiagen, Santa Clarita, CA). Sequenced PCR products were analyzed on an ABI 377 sequencer or at the University of Michigan DNA Sequencing Core facility on either an ABI 3730 or 3700 sequencer.
###end p 28
###begin title 29
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
Primers used for sequencing the MYOC gene.
###end title 29
###begin p 30
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
Primers used in amplification of MYOC exons were also used in sequencing reactions. Primers located in introns were placed far enough away from the exon boundaries to allow visualization of the sequence of the splice sites. Primer pairs 1A, 2, and 3A were used for PCR amplification and sequencing of exons 1, 2, and 3, respectively. Primers 1B and 3B are internal primers that were used for sequencing purposes only.
###end p 30
###begin title 31
Statistical Analysis
###end title 31
###begin p 32
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1153 1155 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
Published reports on the frequency of OAG mutations were compared using several different statistical tests. Because some studies contained expected frequencies of less than 5, Fisher's exact test was chosen to examine the 2x2 contingency tables of individual studies. In tandem with Fisher's exact test, odds ratios and 95% confidence intervals for the odds ratio were calculated. To estimate odds ratios for whole populations based on multiple studies, fixed effect estimates were calculated using a Mantel-Haenszel (MH) model [25]. Homogeneity was evaluated with the Woolf test, in which the p value allows a determination of the appropriateness of combining studies by testing for evidence of effect modification by study group (i.e., testing whether the odds ratios are the same in all studies). For a case-control study, an odds ratio greater than 1 indicates that OAG cases are more likely to have the gene of interest than controls. For 2x2 contingency tables, independence is equivalent to an odds ratio of 1. All statistics were computed using the open source statistical program R 2.3.1 with the packages rmeta 2.12, meta 0.5, and vcd 0.9-7 [26-29].
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
###xml 5 9 5 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
E50K OPTN mutation in a case with normal tension glaucoma
###end title 34
###begin p 35
###xml 45 53 45 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 566 570 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 680 688 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 817 825 817 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 895 903 895 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 962 970 962 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
Case 1, a 52 year old Chilean female (III:1; Figure 1), was diagnosed with NTG at age 42 years and her highest pretreatment IOP was 18 mmHg in both eyes. After bilateral trabeculectomies and betaxolol treatment, her IOPs were 6 mmHg in the right eye and 10 mmHg in the left eye. Gonioscopic exam revealed open angles in both eyes, with iris processes noted circumferentially in both eyes. A dilated funduscopic exam demonstrated advanced glaucomatous cupping with cup-to-disc ratios of 1.0 in both eyes and absence of hemorrhage. Sequence changes were absent in the MYOC gene coding sequence and splice sites. Her family history showed evidence of autosomal dominant inheritance (Figure 1). The E50K mutation was found in three of the proband's four affected relatives that were in the study (II:1, III:2, and III:7; Figure 1). The E50K mutation was absent in the proband's affected aunt (II:3; Figure 1) as well as five unaffected relatives that were screened (Figure 1).
###end p 35
###begin p 36
Lack of complete cosegregation of E50K with glaucoma in the pedigree of a Chilean family. The arrow indicates the proband (Case 1). Filled symbols are affected individuals with NTG, open symbols are individuals who are unaffected or reported to be unaffected. Symbols with a cross indicate individuals who are glaucoma-suspect, symbols with a center dot indicate glaucoma-affected individuals according to family report, and partially filled symbols denote individuals affected with POAG. Diagonal lines mark deceased individuals. Individuals denoted with ++ have E50 alleles on both chromosomes and ones with M+ carry the E50K heterozygous change. Members of generation four are young enough that they are not expected to be affected yet.
###end p 36
###begin title 37
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
691_692insAG OPTN mutation in a case with primary open-angle glaucoma
###end title 37
###begin p 38
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 1083 1087 1083 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1180 1184 1180 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1278 1282 1278 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1286 1291 1286 1291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC.</italic>
###xml 250 257 <span type="species:ncbi:9606">patient</span>
###xml 418 425 <span type="species:ncbi:9606">patient</span>
Case 2 was a female Russian Ashkenazi Jewish immigrant diagnosed with POAG at 80 years of age. Her ocular history was significant for high myopia (right eye -17.75 diopters, left eye -19.00 diopters) and myopic retinal degeneration in both eyes. The patient had a childhood history of measles, a disease that has been identified as a possible contributor to high myopia [30,31]. At the time of the POAG diagnosis, the patient already had dense, 4-quadrant visual field defects in both eyes, attributable to the retinal degeneration, or a long-standing undiagnosed glaucoma, or both. She had cup-to-disc ratios of 0.5 in both eyes and diffuse chorioretinal atrophy. Her IOPs were 22 mmHg in the right eye and 21 mmHg in the left eye. Her IOPs decreased to 17 mmHg in the right eye and 16 mmHg in the left eye at one month after treatment with betaxolol, dipivefrin, and pilocarpine. Over the next several years, her IOPs fluctuated between the low teens and mid-twenties while she underwent treatment with medication, laser treatments, and multiple trabeculectomies. Screening of the OPTN gene revealed an insertion of AG at positions 691 and 692 (691_692insAG) in one copy of the OPTN gene. There were no other sequence variants in the coding sequence or splice sites of either OPTN or MYOC. Little family history information was available. She had a maternal grandfather affected by high myopia, but she didn't know of any other cases of glaucoma in her small family. Her only living relative, a reportedly unaffected son, declined to participate in the study.
###end p 38
###begin title 39
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
R545Q and M98K OPTN sequence variants
###end title 39
###begin p 40
###xml 70 75 <span type="species:ncbi:9606">woman</span>
###xml 360 365 <span type="species:ncbi:9606">woman</span>
The R545Q sequence variant was found in two individuals with OAG. One woman with Filipino ancestry had JOAG diagnosed at 24 years of age and had a maximum known pretreatment IOP of 50 mmHg. Her mother also had POAG and her brother is unaffected. She did not know the diagnostic status of the rest of her relatives in the Philippines. The second case, a Korean woman diagnosed at 55 years of age, had a maximum known IOP of 29 mmHg and an unknown family history of glaucoma.
###end p 40
###begin p 41
Among 36 OAG cases with the M98K mutation, the 26 for whom we have historical IOP data had known maximum IOPs between 16 mmHg and 55 mmHg (mean=29.6 mmHg). Out of the 283 OAG cases who lacked the M98K mutation, 253 had historical IOP data available, with the maximum recorded IOPs ranging from 14 mmHg up to 77 mmHg (mean=29.9 mmHg).
###end p 41
###begin title 42
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
OPTN sequence variants in the whole study cohort
###end title 42
###begin p 43
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 188 195 188 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
Among the 314 OAG cases, we found a total of four (1.2%) individuals who possessed any of the three sequence variants reported by Rezaie and colleagues [9] to be disease-causing variants (Table 4).
###end p 43
###begin title 44
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
Frequency of sequence variants that alter the OPTN protein sequence.
###end title 44
###begin p 45
###xml 185 192 185 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
All case samples were screened and scored for each mutation listed. Absence of a listing for one of the four control groups does not imply that it was screened. Data for M98K appear in Table 5.
###end p 45
###begin p 46
###xml 193 200 193 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
The E50K mutation in Case 1 was the only instance of E50K among the 314 OAG cases (1/314, 0.3%) and in none of 371 controls (<2.7%), and was one of only 11 Hispanic cases screened (1/11, 9.1%; Table 4). E50K was identified in one of the 33 NTG cases (3.0%), but was not present in the 230 POAG or 51 JOAG cases. This mutation was present in 1/11 (9.1%) Hispanic cases and none of 50 Hispanic controls. It was also absent from 86 Caucasian normal controls.
###end p 46
###begin p 47
###xml 150 157 150 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 693 694 693 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
The single instance of 691_692insAG in Case 2 was found among the 314 OAG cases (1/314, 0.3%), and was one of 217 Caucasian OAG cases screened (0.5%; Table 4). This was one of 230 POAG cases (0.4%) and was not present in 116 Caucasian controls, including seven samples that share Ashkenazi Jewish ancestry with the case having the mutation. In addition, 691_692insAG was present in one case in the original report by Rezeai [9] but that report did not provide information on ancestry of that case, so we could not tell whether their case and our case shared ancestral origins. This mutation was also previously reported as being absent from 200 normal control chromosomes of Caucasian origin [9].
###end p 47
###begin p 48
###xml 53 60 53 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
R545Q was present in two of the 314 OAG cases (0.6%; Table 4). It was found once among the 51 JOAG cases (1.9%) and once among the 33 NTG cases (3.0%). Both instances of R545Q were found in individuals of Asian ancestry (2/5, 40.0%). R545Q was also present in 11 of 117 (9.4%) controls of Asian ancestry. The absence of this allele from our Caucasian cases or controls (0/333, <0.3%) concords with previous reports that failed to find it in either cases or controls of European ancestry (0/1457), suggesting that the allele frequency in European populations may be less than 0.1% [9,11,13,22,23,32,33]. Based on our data, we suggest that R545Q may be of low prevalence in African (<0.6%) or Hispanic populations (<1.6%), but our ability to estimate frequencies in these populations is limited because of sample size.
###end p 48
###begin p 49
###xml 81 88 81 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 93 100 93 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
###xml 270 277 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
The M98K sequence variant was found in JOAG, POAG, NTG, and control populations (Table 5 and Table 6). We observed statistically insignificant differences in the frequencies between cases and controls for Africans and Caucasians, the two large sample sets in the study (Table 5). Frequencies in Asian samples (32/122, 26.2%) resembled values for African samples (18/81, 22.2%), while frequencies for Hispanic samples (2/62, 3.2%) seemed more similar to frequencies for Caucasian samples (8/116, 6.9%), but sample sizes were small. Additionally, the Asian samples showed no difference between cases and controls (p value=0.112), but the sample size was small and the use of a predominantly Chinese population to control for findings from a mixed Asian case set was problematic when looking at an allele that showed considerable variation among populations. Thus, although our overall study population showed M98K in 36 of 314 OAG individuals (11.5%) and 58 of 371 controls (15.6%), such pooling of data from different racial/ethnic groups is invalid where population frequencies vary so greatly.
###end p 49
###begin title 50
Frequency of M98K in four populations within our cohort.
###end title 50
###begin p 51
The total enumeration of both cases and controls is listed in the whole population column. Cases are subdivided according to OAG type, either JOAG, POAG, or NTG. A two-sided Fisher's exact test p value indicated no statistical significance for association between cases and controls in each ancestry category. Woolf's test for homogeneity among the ancestry frequencies yielded a p value of 0.312, indicating that the ancestral subdivisions are statistically similar.
###end p 51
###begin title 52
Comparison of R545Q frequency in different populations.
###end title 52
###begin p 53
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
The asterisks denote a calculation based on adding 0.5 to each cell in cases with a zero cell frequency, otherwise the value is nonexistent. Lower and upper bounds refer to the individual study 95% confidence interval around the odds ratio for a fixed effects Mantel-Haenszel model. Information from Leung et al. [35] were omitted because it duplicated that contained in Fan et al. [15]. Data from Toda et al. [37] were omitted because it duplicated information contained in Tang et al. [20]. In the Europe category, only the data regarding Caucasians (Iowa and Australia) in Alward et al. [11] were enumerated, while the reported cases with pigmentary, developmental, and exfoliative data were omitted.
###end p 53
###begin p 54
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 138 145 138 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 169 173 169 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 441 448 441 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
Screening identified two instances of E322K in both cases and controls - a change previously reported to be associated with glaucoma [9] (Table 4). We also found silent OPTN coding sequence polymorphisms, including L32L, T34T, L41L, E63E, A134A, and S321S, as well as previously reported intronic sequence variants [4,10,11,20,24,34,35]. We did not find Ile88Val or Ala99Ser in our case populations, but did observe them among our controls (Table 4).
###end p 54
###begin title 55
Pooled data on R545Q
###end title 55
###begin p 56
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 364 371 364 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
###xml 558 566 558 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 568 575 568 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
###xml 618 619 618 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 731 738 731 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
R545Q was present in our Asian data set, but absent from the other three populations we screened. We found no significant differences in allele frequencies between cases and controls for R545Q. This agrees with many of the other published studies, although it should be noted that Mukhopadhyay et al. [19] did report the case-control difference to be significant (Table 6). Evaluation of odds ratios and frequencies for each of the Asian studies showed no statistically significant differences between case and control values for any of the Asian data sets (Figure 2, Table 6). With the exception of the Rezaie study [9], R545Q has been reported only in Chinese, Japanese, Korean, Filipino, Indian, and mixed-ancestry populations (Table 6).
###end p 56
###begin p 57
###xml 73 74 73 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 366 367 366 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
R545Q log odds ratios and allele frequences in Asian population studies. A shows the odds ratios with 95% confidence interval bars for individual Asian studies, and pooled results for Japan, China, and both in open angle glaucoma (OAG) cases versus controls. Odds ratios and confidence intervals are fixed effect estimates resulting from the Mantel-Haenszel method. B shows the case (OAG, filled circle) and control (open circle) proportion observed for each study. Total sample sizes are listed along the right-hand margin. None of the differences between case and control frequencies are statistically significant in a comparison of the odds ratios (as readily observed from the odds ratio confidence intervals) and frequencies of R545Q mutations in any of the Asian populations studied.
###end p 57
###begin p 58
###xml 176 183 176 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
###xml 419 426 419 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t7">Table 7</xref>
###xml 495 502 495 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t6">Table 6</xref>
###xml 815 822 815 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t7">Table 7</xref>
Our Asian data set is small, so we examined the possibility of pooling data from multiple studies. Because of observed variation in allele frequencies among studies (0.6-6.8%; Table 6), we questioned whether the data could be validly combined. Using the Woolf test for heterogeneity to address this question, we found no statistically significant study-based stratification within the individual populations for R545Q (Table 7). This means that it is reasonable to take data from the studies in Table 6 and pool them for a given population from multiple studies under a model of homogeneity. When pooled, we found no statistically significant difference between case and control values for the combined Asian data set (p value=0.541), nor for the separate Chinese (p value=0.89) or Japanese (p value=0.43) subsets (Table 7). The same lack of difference was true when considering only NTG cases.
###end p 58
###begin title 59
Aggregate statistical summaries in Asian populations screened for R545Q.
###end title 59
###begin p 60
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 626 628 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
Results from computing the upper and lower 95% confidence interval bounds around the odds ratio indicate that none of the Asian divisions are statistically different from an odds ratio of 1. The Woolf test for homogeneity indicates that across studies within each ancestry group the odds ratios are statistically equivalent (i.e., homogeneous, because a p value less than 0.05 would indicate heterogeneity [25]). A two-sided Fisher's exact test on the pooled frequencies was computed for those instances when the Woolf test indicated homogeneity at the 0.05 level. The ancestry groups are collated for China from Chen et al. [14] and Fan et al. [15]; and for Japan from Alward et al. [11], Funayama et al. [16], Fuse et al. [17], Tang et al. [20], and Umeda et al. [21]. The Asia listing includes data pooled from the China and Japan categories. Only Fan et al. [15] report on NTG for China.
###end p 60
###begin title 61
Pooled data on M98K
###end title 61
###begin p 62
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t8">Table 8</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
We found no evidence of significant difference between case and control frequencies for M98K in our Asian, African, Hispanic, or Caucasian populations (Table 8). Fuse and Alward reported statistically significant evidence of association of M98K with OAG in the Japanese population, although Alward indicated that this difference becomes nonsignificant when adjusted for testing multiple times [11,17]. Other studies do not report a significant case-control difference [11-24].
###end p 62
###begin title 63
Frequency of M98K in individuals from different populations.
###end title 63
###begin p 64
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 844 846 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 864 865 864 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 890 892 890 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
Under the fixed effects Mantel-Haenszel model, individual study 95% confidence interval bounds around the odds ratio are given. For compatibility with much of the published literature the two-sided Fisher's exact test p values are given for each study. Although the presence of M98K mutations in OAG cases appears to be statistically significant relative to controls, Alward et al. [11] reported that when multi-testing is taken into account their result becomes nonsignificant. Information from Leung et al. [35] was omitted because it duplicated the information contained in Fan et al. [15]. Data from Toda et al. [37] were omitted because they duplicated the observations contained in Tang et al. [20]. Pigmentary and exfoliative data were omitted from the Europe (Caucasians living in Iowa and Australia) samples reported by Alward et al. [11]. Rezaie et al. [9] reported a p value=2.18-7.
###end p 64
###begin p 65
###xml 236 243 236 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t8">Table 8</xref>
###xml 248 255 248 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t9">Table 9</xref>
Previous studies supported our finding that M98K allele frequences are much higher in populations of Asian (555/2818, 19.7%) or African (38/169, 22.5%) ancestries than in Caucasian (179/3149, 5.7%) or Hispanic (2/61, 3.3%) populations (Table 8 and Table 9). Thus, ancestry would be a significant confounding variable when attempting to analyze data pooled from different populations.
###end p 65
###begin title 66
Aggregate statistical summaries for populations screened for M98K.
###end title 66
###begin p 67
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 185 187 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 516 518 516 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 785 787 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 1346 1347 1346 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
The ancestry groups are collated for China: Chen et al. [14] and Fan et al. [15]; Japan: Alward et al. [11], Funayama et al. [16], Fuse et al. [17], Tang et al. [20], and Umeda et al. [21]; Europe: Alward et al. [11], Aung et al. [12], Baird et al. [13], Jansson et al. [32], Melki et al. [18], Rakhmanov et al. [33], Rezaie et al. [9], and Weisschuh et al. [22]. Asia is the pooling of the China and Japan categories. The total combines all published studies from the lines above with the addition of Craig et al. [38], Hauser et al. [36], Mukhopadhyay et al. [19], Sripriya et al. [39], Wiggs et al. [23], and Willoughby et al. [24]. The Europe-NTG group consists of the data from Alward et al. [11], Aung et al. [12], Baird et al. [13], Rakhmanov et al. [33], and Weisschuh et al. [22]. Results from computing the upper and lower 95% confidence interval bounds around the odds ratio indicate that some studies are statistically different than an odds ratio of 1. The Woolf test for homogeneity indicated that across studies within each ancestry group which of the odds ratios were statistically equivalent (i.e., heterogeneity is indicated by a p value less than 0.05 [25]). A two-sided Fisher's exact test on the pooled frequencies is given for those instances when the Woolf test indicated homogeneity at the 0.05 level. When Rezaie et al. [9] data are excluded the Europe group, then the odds ratio becomes 1.33 with a 95% confidence interval of (0.90, 1.98), Woolf p value of 0.512, and a Fisher's exact test p value of 0.072.
###end p 67
###begin p 68
###xml 301 309 301 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 728 736 728 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 738 745 738 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t8">Table 8</xref>
###xml 1032 1040 1032 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
If we consider specific defined subpopulations, where there should be less concern about ancestry serving as a confounding variable, then we are left with concerns about differences observed not just between but also within populations. When we compared the different Asian studies using odds ratios (Figure 3), the aggregate Asian data, the aggregate Japanese data, the data produced by our study, and by the individual studies of Umeda et al. [21], Fuse et al. [17], and Alward et al. [11], we found each showed significant evidence of a difference between cases and controls. When we evaluated allele frequencies for the various Asian data sets, we saw dramatic differences in allele frequencies among the different studies (Figure 3, Table 8). Also, the control values showed much greater variation among studies than the case values. The control values from some studies are higher than the case values from other studies, even though within each separate study the case frequencies are always higher than control frequencies (Figure 3). With regard to our study, in which a small number of samples came from diverse Asian regions, the observed difference could be due to the limited case sample size, differential representation of M98K within the Asian population, case versus control status, or some combination of the three.
###end p 68
###begin p 69
###xml 139 140 139 140 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 454 455 454 455 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1063 1064 1063 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1229 1231 1229 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
Studywise differences appear in Japanese populations when odds ratios and frequencies of M98K mutations are compared. The left-hand graph (A) shows the odds ratios with 95% confidence interval bars for individual Asian studies and pooled results for Japan, China, and both in open angle glaucoma (OAG) cases versus controls. Odds ratios and confidence intervals are fixed effect estimates resulting from the Mantel-Haenszel method. The right-hand graph (B) shows the case (OAG, filled circle) and control (open circle) proportions observed for each study. Total sample sizes are listed along the right-hand margin. Larger samples have both narrower confidence intervals and shorter distance between fractions observed for cases and controls. Studies inconsistently estimate the odds of OAG versus controls carrying an M98K mutation, with larger studies (more than 400 total cases and controls) estimating no statistically significant difference. Other population estimates are not shown, because, among the European population-based studies, only Rezaie's study [9] showed a statistically significant difference. The single study on India yielded a significant odds ratio, but no other comparable populations have been reported [19].
###end p 69
###begin p 70
###xml 198 205 198 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t9">Table 9</xref>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t9">Table 9</xref>
###xml 989 996 989 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t9">Table 9</xref>
###xml 1072 1073 1072 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1334 1341 1334 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t9">Table 9</xref>
The results of the Woolf test for heterogeneity indicated that there was something noncomparable about the M98K findings from a number of the studies that reported results for the same populations (Table 9). In the case of the Japanese data set, pooled data showed M98K frequencies of 18.2% (220/1208) in cases versus 11.6% (77/661) in controls (p value=0.0002), but results of the Woolf test led us to suspect that we may be combining noncomparable data sets (p value=0.046). In the case of the European data set, Fisher's exact test indicated that there was a statistically significant difference between cases and controls (p value=0.001), but again the Woolf test identified heterogeneity among the data sets (p value=0.005; Table 9). When we pooled the worldwide data from the entire set of published studies, we saw a significant difference between cases and controls (p value=0.00000004), but again, testing for heterogeneity indicated that it may be invalid to pool these studies (Table 9; p value=0.0018). Interestingly, if we removed data from the Rezaie study [9], which indicated Caucasian controls but did not specify its case population composition, the remaining Caucasian data sets appeared to be homogeneous (p value=0.512) and Fisher's exact test indicated no significant difference between case and control values (Table 9; p value=0.072). Fewer studies distinguish observations for NTG only. For those studies that provided data for NTG frequencies, we saw that both the Japanese and European populations showed homogeneity across studies. However, Fisher's exact testing of pooled studies showed opposing results between Japanese (p value=0.00002) and European (p value=0.58) populations.
###end p 70
###begin p 71
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t8">Table 8</xref>
The case versus control difference for the Hispanic data are also intriguing, with M98K case values of 1/11 (9.1%) and control values of 1/50 (2.0%). Our small Hispanic data set was not well-powered for statistical testing, but this represented an initial view of a population under represented in previous studies (Table 8). Given that our Hispanic data set represented cross-continental cases from North, Central, and South America, we have to wonder whether the apparent differences in M98K allele frequences was simply due to small sample size, or rather might be attributed to differential allele frequencies correlated with geographic origins of samples rather than case-control status.
###end p 71
###begin title 72
Discussion
###end title 72
###begin p 73
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
In our study of 314 individuals with OAG, we found 42 individuals with sequence variants predicted to alter the protein coding sequence. This included three OPTN variants previously reported to be disease-causing variants-E50K, 691_692insAG, and R545Q, as well as the M98K variant previously reported as a risk factor [9].
###end p 73
###begin p 74
###xml 314 318 314 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 781 788 781 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t8">Table 8</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 830 832 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
This is the second time the 691_692insAG mutation has been reported. Both times it has been identified in case populations but not seen in controls. It is the first report of 691_692insAG in an individual of Russian Ashkenazi Jewish ancestry, and ancestry is unavailable for the previously reported case. Although OPTN defects were originally reported in a population of primarily NTG cases, we found this variant in an individual with modestly elevated IOP (22 mmHg). The shift in the reading frame that it causes and the fact that it is seen among cases but not controls suggests that it could be a causative variant. However, if we combine data from all studies, we see it in 2/3677 cases (0.0005%) in the studies that used protocols that would have detected it (all studies in Table 8 except Aung [12], Melki [18], and Wiggs [23]). Only a fraction of the 2,270 controls from those studies screened the whole sequence from all controls, so they would not have been highly likely to detect this variant among the controls even if the control frequency were equal to the case frequency. Thus, while it is tempting to say that a variant seen only in two cases might be causative, the available numbers can only support the conclusion that 691_692insAG event is a rare occurence.
###end p 74
###begin p 75
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 650 652 650 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 698 700 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 707 709 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
We report here the first observation of the E50K change in a Caucasian Hispanic individual. The observation of E50K at a frequency of 0.3% in our cases is consistent with reports of frequencies in OAG populations of 0.1% by Alward et al. [11], 0.6% by Aung et al. [12], and 0.6% by Hauser et al. [36]. The NTG subset is reported to have E50K at a higher prevalence of 13.5% (7/52),1.5% (2/132), 1.5% (1/67), and 2.9% (1/34) in studies by Rezaie et al. [9], Aung et al. [12], Hauser et al. [36], and ourselves, respectively. Many other studies found no evidence of this mutation, including reports of its absence from 237 cases with Chinese ancestry [14,35] and 961 cases with Japanese ancestry [11,14,16,17,20,21,35,37], which supports the supposition that this is a polymorphism private to the Caucasian and Hispanic populations. Variation in frequencies observed among studies may be affected by the ancestry of the population, the fraction of the cohort with familial glaucoma, and differences in specific diagnoses included in the study. Failure to see complete cosegregation of E50K with glaucoma (i.e., we have one OAG case in a family lacking the E50K mutation) raises questions about whether we are observing a phenocopy or whether E50K is not the cause of the glaucoma in this family.
###end p 75
###begin p 76
Our data and the compiled evidence from more than a dozen other studies support the idea that R545Q may be a private polymorphism of Asian populations. Although our Asian data set provides marginal evidence for a difference in R545Q allele frequency between cases and controls, it is a small population and the results are not statistically significant. When we pooled our data with data from other studies there did not appear to be any evidence to support a role for R545Q as a disease causing variant.
###end p 76
###begin p 77
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 920 927 920 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t9">Table 9</xref>
###xml 1015 1023 1015 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 1147 1154 1147 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t9">Table 9</xref>
###xml 1156 1164 1156 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
We found the M98K variant in all four populations screened, but evaluation of all of the published studies leaves unresolved the issue of whether or not M98K is a risk factor for glaucoma. A similar conclusion was drawn by Craig et al. [38] but they did not analyze the population (ancestry) structure of the data for the allele. Several studies find evidence for association, while others do not. Evaluation of the published data in addition to our own indicates that there is considerable variation in allele frequencies, not only among populations, but also within populations. This variant is found in Asian and African populations at more than twice the frequency seen in Caucasian and Hispanic populations. Comparison of findings from different studies indicates large variations in allele frequencies in different study populations within Japanese (MH p value=0.00038) and Chinese (MH p value=0.118) populations (Table 9). The case-control difference is much smaller within Caucasian or African populations (Figure 3), and data on Caucasian populations show less variation between studies than the data on Japanese and Chinese populations (Table 9, Figure 3).
###end p 77
###begin p 78
###xml 334 342 334 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t10">Table 10</xref>
###xml 524 532 524 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 724 725 723 724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 733 734 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 888 896 882 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t10">Table 10</xref>
There are a number of confounding factors that might contribute to the observed variability of allele frequency between Asian populations. Differential allele frequencies within a population could result from founder effects. At this point, there is not enough information available regarding origins of the different subpopulations (Table 10) to allow for evaluation of the likelihood of a founder effect. There appears to be a correlation between total sample size and the difference between case and control frequencies (Figure 2), although the published studies seem to be adequately powered (for Fisher's exact test, the power, or probability to reject the null hypothesis when it is true, is 0.76 for the parameters pi1=0.2, pi2=0.1, where each sample size is 200 and alpha=0.05). An alternative confounding factor could be the result of the different screening techniques applied (Table 10); however, there is no obvious correlation of high allele frequencies with one screening approach and low allele frequencies with a different technique. Selective under-representation of an allele in a data set relative to the actual allele frequency could result if M98K were in linkage disequilibrium with a neighboring polymorphism contained within the sequence of a primer used in amplification or sequencing in some studies, but not others. Some of the papers do not present the primer sequences and the available primer sequence data do not provide support for this idea. Additional contributions to variability between studies could include differences in diagnostic inclusion and exclusion criteria and fraction of familial glaucoma within each cohort. Thus, the extant data do not allow us to distinguish between technical, ascertainment and demographic models for the observed differences in M98K allele frequencies between different studies of the same population.
###end p 78
###begin title 79
M98K population data sources and screening methods ordered by ancestry.
###end title 79
###begin p 80
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
The following methodologies were used to screen samples for variants. We omitted two studies: Wang et al. [40], a Filipino population, and Forsman et al. [34], a population from south Finland, because they are small family-based studies without population data. SSCP: single-strand conformation polymorphism. DHPLC: denaturing high-performance liquid chromatography. HTCSGE: High throughput conformation sensitive gel electrophoresis. RFLP: Restriction Fragment Length Polymorphisms.
###end p 80
###begin p 81
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
An alternative approach to evaluation of whether the M98K allele is involved in glaucoma is through the study of cosegregation in families. Wiggs et al. [23] reported lack of cosegregation in families. An accompanying population-based portion of that study [23] also failed to find association of M98K with glaucoma in a population of mostly European ancestry.
###end p 81
###begin p 82
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
One alternative explanation for why some studies find association, yet others do not, might be that there is a valid statistical difference between the case and control populations but that the M98K allele is actually associated with some other variable that differs between cases and controls, or has been excluded from cases but not controls. An obvious example of this would be IOP. The Rezaie et al. study [9] looked at mostly NTG families, while there was a lot of variation in the extent to which NTG was represented in the different populations in the other studies. If M98K is actually responsible for reducing IOP, or for preventing the rise of IOP, but is not actually causing glaucoma, then we would expect exclusion of individuals with elevated IOP from the cases would bias the M98K frequency in the cases as compared to the controls even if M98K were not actually causing glaucoma. Melki et al. [18] offered the view that M98K is associated with lower IOP. In our data set we found that cases with the M98K mutation had known maximum IOP values ranging from 16 mmHg to 55 mmHg (mean=29.6 mmHg) while those who lacked the M98K mutation had maximum recorded IOP values ranging from 14 mmHg in an NTG case up to 77 mmHg (mean=29.9 mmHg). Thus, in our data set there was no obvious difference in maximum known IOP between those with and those without M98K.
###end p 82
###begin p 83
###xml 143 145 143 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-7</sup>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 1254 1255 1254 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
The original report by Rezaie provided apparently compelling statistical evidence that M98K is a glaucoma risk factor with a p value of 2.18x10-7. The other studies that found any support for M98K association with glaucoma found only weak evidence of this association. It remains unclear what the differences are between the studies that could account for the differences in study outcome. One key issue for M98K appears to be the great variability of allele frequency reported in different studies and different populations. This would be a problem if the case population in the Rezaie et al. study [9] contained multiple populations or an admixed population that self-identified as Caucasian. In the Rezaie et al. study [9], both E50K, an apparently private Caucasian polymorphism, and R545Q, an apparently private Asian polymorphism, were in the same study cohort. While this could mean that their undescribed case population was a mixed race group, it is also the kind of thing that can happen in a fairly admixed urban population when using self identification as the basis for applying racial/ethnic classification, even when setting out to identify a relatively homogeneous population. Thus, there is the possibility that the Rezaie et al. study [9] outcome differs from the others because of differences in diagnostic inclusion and exclusion criteria or other unidentified factors, but it could also be the result of studying an allele that varies significantly between and within populations - something that can happen even when making efforts to carry out adequate matching of cases and controls.
###end p 83
###begin p 84
Thus the findings on M98K are currently contradictory, with some studies finding association and other studies finding no support for association, and with the differences in study outcome not assorting according to population or technology used. Because there are such substantial differences in allele frequencies between the different studies and between and within populations, it is likely that a final resolution of this question will require the following: The screening to take place by technologies selected for precision rather than high throughput; the study be adequately powered; matching of cases and controls for ancestry be highly rigorous and matched for subpopulations rather than simply matching for one of a handful of racial or ethnic categories; inclusion and exclusion criteria be carefully defined, that tests for association with associated variables such as IOP be carried out in addition to tests for association with the primary glaucoma status variable; and population substructure analysis be included in the analysis to help deal with apparent differences within populations that can be difficult to control.
###end p 84
###begin p 85
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 204 208 204 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
This study has contibuted additional evidence of association of OPTN E50K with glaucoma, and reported an additional instance of the 691_692insAG sequence variant. We have also provided new information on OPTN in populations of African and Hispanic ancestry. Evaluation of data from more than a dozen studies indicated no association of R545Q with glaucoma in most populations. Combined analysis of more than a dozen studies suggests that M98K is associated with NTG in Asian, but not Caucasian study populations, but these results must be interpreted with great caution because of the large differences in allele frequencies between and within populations.
###end p 85
###begin title 86
Acknowledgements
###end title 86
###begin p 87
The authors thank Dr. Alfonzo Mendoza A. for his contributions to this paper. Financial support came from NIH EY07003 (Core grant, Kellogg Eye Center), NIH EY09580 (J.E.R.), and NIH EY11671 (J.E.R.) from the National Institutes of Health, Bethesda, MD, a fellowship from the Pan American Association of Ophthalmology, Arlington, TX, (R.A-L.), an unrestricted grant from Research to Prevent Blindness, Inc., New York, NY, to the Kellogg Eye Center, and by the Van Arnam Glaucoma Research Fund of the University of Michigan Department of Ophthalmology and Visual Sciences, Ann Arbor, MI. The authors have no financial or proprietary conflicts relevant to the content of this paper.
###end p 87
###begin title 88
References
###end title 88
###begin article-title 89
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 89
###begin article-title 90
Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey.
###end article-title 90
###begin article-title 91
Complex genetics of glaucoma susceptibility.
###end article-title 91
###begin article-title 92
Assignment of a locus (GLC3A) for primary congenital glaucoma (Buphthalmos) to 2p21 and evidence for genetic heterogeneity.
###end article-title 92
###begin article-title 93
A second locus (GLC3B) for primary congenital glaucoma (Buphthalmos) maps to the 1p36 region.
###end article-title 93
###begin article-title 94
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.
###end article-title 94
###begin article-title 95
Age-dependent prevalence of mutations at the GLC1A locus in primary open-angle glaucoma.
###end article-title 95
###begin article-title 96
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 96
###begin article-title 97
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
###end article-title 97
###begin article-title 98
Localization of the fourth locus (GLC1E) for adult-onset primary open-angle glaucoma to the 10p15-p14 region.
###end article-title 98
###begin article-title 99
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.
###end article-title 99
###begin article-title 100
Prevalence of optineurin sequence variants in adult primary open angle glaucoma: implications for diagnostic testing.
###end article-title 100
###begin article-title 101
Analysis of optineurin (OPTN) gene mutations in subjects with and without glaucoma: the Blue Mountains Eye Study.
###end article-title 101
###begin article-title 102
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Study on the optic neuropathy induced response protein gene mutation in Chinese patients with primary open-angle glaucoma.
###end article-title 102
###begin article-title 103
###xml 107 115 <span type="species:ncbi:9606">patients</span>
SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients.
###end article-title 103
###begin article-title 104
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma.
###end article-title 104
###begin article-title 105
Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population.
###end article-title 105
###begin article-title 106
###xml 88 96 <span type="species:ncbi:9606">patients</span>
The M98K variant of the OPTINEURIN (OPTN) gene modifies initial intraocular pressure in patients with primary open angle glaucoma.
###end article-title 106
###begin article-title 107
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Evaluation of Optineurin as a candidate gene in Indian patients with primary open angle glaucoma.
###end article-title 107
###begin article-title 108
###xml 89 97 <span type="species:ncbi:9606">patients</span>
The association between Japanese primary open-angle glaucoma and normal tension glaucoma patients and the optineurin gene.
###end article-title 108
###begin article-title 109
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Clinical relevance of optineurin sequence alterations in Japanese glaucoma patients.
###end article-title 109
###begin article-title 110
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients.
###end article-title 110
###begin article-title 111
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Lack of association of mutations in optineurin with disease in patients with adult-onset primary open-angle glaucoma.
###end article-title 111
###begin article-title 112
Defining the pathogenicity of optineurin in juvenile open-angle glaucoma.
###end article-title 112
###begin article-title 113
The relationship between measles and myopia.
###end article-title 113
###begin article-title 114
A prospective study of ocular abnormalities in hearing impaired and deaf students.
###end article-title 114
###begin article-title 115
Analysis of rare variants and common haplotypes in the optineurin gene in Swedish glaucoma cases.
###end article-title 115
###begin article-title 116
Mutations and polymorphisms in the genes for myocilin and optineur in as the risk factors of primary open-angle glaucoma.
###end article-title 116
###begin article-title 117
The role of TIGR and OPTN in Finnish glaucoma families: a clinical and molecular genetic study.
###end article-title 117
###begin article-title 118
Different optineurin mutation pattern in primary open-angle glaucoma.
###end article-title 118
###begin article-title 119
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Distribution of optineurin sequence variations in an ethnically diverse population of low-tension glaucoma patients from the United States.
###end article-title 119
###begin article-title 120
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Mutations in the optineurin gene in Japanese patients with primary open-angle glaucoma and normal tension glaucoma.
###end article-title 120
###begin article-title 121
The role of the Met98Lys optineurin variant in inherited optic nerve diseases.
###end article-title 121
###begin article-title 122
###xml 22 30 <span type="species:ncbi:9606">patients</span>
OPTN gene: profile of patients with glaucoma from India.
###end article-title 122
###begin article-title 123
Absence of myocilin and optineurin mutations in a large Philippine family with juvenile onset primary open angle glaucoma.
###end article-title 123

